SEC Form 4 · accession 0001127602-17-022041
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Patusky
Director
Period of report
Jun 21, 2017
Accepted (ET)
Jun 22, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 21, 2017 | M | 1,750 | $0.00 | A | 1,750 | D | |
| Common Stock | holding | — | — | — | 1,300 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Jun 21, 2017 | M | 1,750 | D | — | — | Common Stock | 1,750 | 0 | D |
Explanation of responses
- F1Shares received upon vesting of restricted stock units on June 21, 2017. Restricted stock units converted on a one-for-one basis into shares of common stock.
- F2Restricted stock units were granted on June 21, 2016, and vested on June 21, 2017. The entire number of restricted stock units converted into shares of common stock upon vesting.